Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:240-247
Published online before print July 13, 2006, doi: 10.1161/01.RES.0000237021.65103.24
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/3/240    most recent
01.RES.0000237021.65103.24v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, X.
Right arrow Articles by Kourembanas, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, X.
Right arrow Articles by Kourembanas, S.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
Right arrow Pulmonary circulation and disease
(Circulation Research. 2006;99:240.)
© 2006 American Heart Association, Inc.


Molecular Medicine

Hypoxia Regulates Bone Morphogenetic Protein Signaling Through C-Terminal–Binding Protein 1

Xinqi Wu, Mun Seog Chang, S. Alex Mitsialis, Stella Kourembanas

From the Department of Medicine, Division of Newborn Medicine, Children’s Hospital Boston and Harvard Medical School, Boston, Mass.

Correspondence to Dr Stella Kourembanas, Division of Newborn Medicine, Children’s Hospital, Enders 9, 300 Longwood Ave, Boston, MA 02115. E-mail stella.kourembanas{at}childrens.harvard.edu

Bone morphogenetic protein receptor 2 (BMPR2) mutations have been linked to familial pulmonary arterial hypertension (PAH), but the molecular pathways leading to this severe pathology remain poorly characterized. We report that hypoxia, a paramount stimulus for the development of pulmonary hypertension, suppresses the expression of inhibitor of differentiation 1 (Id1), a downstream target of the BMPR2 pathway, in human pulmonary artery smooth muscle cells (HPASMC). This attenuation of BMP signaling by hypoxia is conveyed through a repression of the transcriptional activity of the BMP responsive element (BRE) through mechanisms involving the transcriptional corepressor C-terminal–binding protein 1 (CtBP-1) and histone deacetylases (HDACs). Concordantly, overexpression of CtBP-1 suppressed BMP signaling, whereas small interfering RNA against CtBP-1 efficiently enhanced BMP stimulation of Id1 gene expression. Scavengers of reactive oxygen species had no effect on the hypoxic regulation of Id1, but, significantly, enhancement of the intracellular NADH/NAD+ ratio mimicked the effects of hypoxia. These results indicate that attenuation of BMP signaling can occur through modulation of CtBP-1 activity by hypoxia-induced changes in the NADH/NAD+ ratio. Our findings, taken in context with the observed prevalence of pulmonary arterial hypertension associated with BMPR2 mutations, define converging molecular pathways that lead to the development of pulmonary hypertension, through either genetic or epigenetic loss of function of components of the BMP signaling pathway.


Key Words: hypoxia • bone morphogenetic protein • C-terminal–binding protein 1 • inhibitor of differentiation 1 • histone deacetylases • pulmonary hypertension




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. M. Costello, K. Howell, E. Cahill, J. McBryan, M. Konigshoff, O. Eickelberg, S. Gaine, F. Martin, and P. McLoughlin
Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L272 - L284.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Yang, R. J. Davies, M. Southwood, L. Long, X. Yang, A. Sobolewski, P. D. Upton, R. C. Trembath, and N. W. Morrell
Mutations in Bone Morphogenetic Protein Type II Receptor Cause Dysregulation of Id Gene Expression in Pulmonary Artery Smooth Muscle Cells: Implications for Familial Pulmonary Arterial Hypertension
Circ. Res., May 23, 2008; 102(10): 1212 - 1221.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. E. Fredenburgh, O. D. Liang, A. A. Macias, T. R. Polte, X. Liu, D. F. Riascos, S. W. Chung, S. L. Schissel, D. E. Ingber, S. A. Mitsialis, et al.
Absence of Cyclooxygenase-2 Exacerbates Hypoxia-Induced Pulmonary Hypertension and Enhances Contractility of Vascular Smooth Muscle Cells
Circulation, April 22, 2008; 117(16): 2114 - 2122.
[Abstract] [Full Text] [PDF]